Iron-based accelerator for curing resins

Patent metadata

Field	Value
Publication number	US-9428631-B2
Application number	US-201214423197-A
Country	US
Kind code	B2
Filing date	Aug 29, 2012
Priority date	Aug 29, 2012
Publication date	Aug 30, 2016
Grant date	Aug 30, 2016

Abstract

Accelerator solution suitable for forming a redox system with peroxides, comprising (i) an iron compound selected from iron carboxylates, iron 1,3-dioxo complexes, and iron dicylcopentadienyl complexes, (ii) a compound of a second transition metal; the weight ratio of iron:second transition metal being in the range 3:1 to 200:1, with the proviso that the accelerator solution is essentially free of ascorbic acid.

First claim

The invention claimed is:

1. An accelerator solution suitable for forming a redox system with peroxides, comprising:
an iron compound selected from the group consisting of iron carboxylates, iron 1,3-dioxo complexes, and iron dicylcopentadienyl complexes,
(ii) a compound of a second transition metal; the weight ratio of iron:second transition metal being in the range of 3:1 to 200:1, and
(iii) a solvent selected from the group consisting of diethyl phosphate, dibutyl phosphate, tributyl phosphate, triethyl phosphate, and dibutyl phosphite,
wherein the second transition metal is Co or Mn, and
with the proviso that the accelerator solution contains less than 1 wt % of ascorbic acid.

2. The accelerator solution according to claim 1 , wherein the iron compound is present in the solution, determined as metal, in an amount of 50-5000 mmol/l.

3. The accelerator solution according to claim 1 , wherein the second transition metal is present in the solution in an amount of 10-1000 mmol/l.

4. The accelerator solution according to claim 1 , further comprising an alkali or alkaline earth metal compound, a second phosphorous-containing compound, and/or a 1,3-diketone.

5. A two component composition comprising a first component and a second component, the first component comprising a pre-accelerated resin composition comprising
(i) a curable resin,
(ii) an iron compound selected from the group consisting of iron carboxylates, iron 1,3-dioxo complexes, and iron dicyclopentadienyl complexes,
(iii) a compound of a second transition metal; the weight ratio of iron:second transition metal being in the range of 3:1 to 200:1,
wherein the second transition metal is Co or Mn, and

(iv) a solvent selected from the group consisting of diethyl phosphate, dibutyl phosphate, tributyl phosphate, triethyl phosphate, and dibutyl phosphite,
with the proviso that the pre-accelerated resin contains less than 0.01 wt % of ascorbic acid, and
the second component comprises a peroxide selected from the group consisting of organic hydroperoxides, ketone peroxides, peroxycabonates, and peroxyesters.

6. The two-component composition according to claim 5 , wherein the iron compound is present in the pre-accelerated resin, determined as metal, in an amount of 1-75 mmol/kg resin.

7. The two-component composition according to claim 5 , wherein the second transition metal is present in the pre-accelerated resin, determined as metal, in an amount of 0.005-0.5 mmol/kg resin.

8. The two-component composition according to claim 5 , wherein the pre-accelerated resin further comprises an alkali or alkaline earth metal compound, a second phosphorous-containing compound, and/or a 1,3-diketone.

9. The two-component composition according to claim 5 , wherein the curable resin is an unsaturated polyester resin, a vinyl ester resin, or a (meth)acrylate resin.

10. A pre-accelerated resin composition comprising:
(i) a curable resin,
(ii) an iron compound selected from the group consisting of iron carboxylates, iron 1,3-dioxo complexes, and iron dicyclopentadienyl complexes,
(iii) a compound of a second transition metal; the weight ratio of iron:second transition metal being in the range of 3:1 to 200:1,
wherein the second transition metal is Co or Mn, and

(iv) a solvent selected from the group consisting of diethyl phosphate, dibutyl phosphate, tributyl phosphate, triethyl phosphate, and dibutyl phosphite,
with the proviso that the pre-accelerated resin contains less than 0.01 wt % of ascorbic acid.

11. The pre-accelerated resin composition according to claim 10 , wherein the iron compound is present in the pre-accelerated resin, determined as metal, in an amount of 1-75 mmol/kg resin.

12. The pre-accelerated resin composition according to claim 10 , wherein the second transition metal is present in the pre-accelerated resin, determined as metal, in an amount of 0.005-0.5 mmol/kg resin.

13. The pre-accelerated resin composition according to claim 10 , wherein the pre-accelerated resin further comprises an alkali or alkaline earth metal compound, a second phosphorous-containing compound, and/or a 1,3-diketone.

14. The pre-accelerated resin composition according to claim 10 , wherein the curable resin is an unsaturated polyester resin, a vinyl ester resin, or a (meth)acrylate resin.

Assignees

• Talma Auke Gerardus
• Koers Frederik Willem Karel
• Reijnders Johannes Martinus Gerardus Maria
• Akzo Nobel Chemicals Int Bv

Inventors

• Talma Auke Gerardus
• Koers Frederik Willem Karel
• Reijnders Johannes Martinus Gerardus Maria

Classifications

• C08K2003/0856

  Iron · CPC title

• C08K5/56

  Organo-metallic compounds, i.e. organic compounds containing a metal-to-carbon bond · CPC title

• C08K5/098 Primary

  Metal salts of carboxylic acids · CPC title

• C08K5/07

  Aldehydes; Ketones · CPC title

• C08K5/0091

  Complexes with metal-heteroatom-bonds · CPC title